Related references
Note: Only part of the references are listed.A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
S. H. Park et al.
ANNALS OF ONCOLOGY (2021)
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer
Annamaria Agnes et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers
Lucy X. Ma et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study
Annamaria Agnes et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study
I. Mokadem et al.
GASTRIC CANCER (2019)
Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy
Shu-Bei Wang et al.
RADIATION ONCOLOGY (2019)
Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection
Bochao Zhao et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy
Naruhiko Ikoma et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all
Alberto Biondi et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Differences in the multimodal treatment of gastric cancer: East versus west
Ashley Russo et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer
Shu-Qiang Yuan et al.
JOURNAL OF CANCER (2017)
Surgical anatomy of gastric lymphatic drainage
Maria Carmen Lirosi et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
Ralf Gertler et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems
Yoon Young Choi et al.
PLOS ONE (2016)
The Prognostic Significance of an R1 Resection in Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy
Jurrien Stiekema et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Anatomic Extent of Metastatic Lymph Nodes: Still Important for Gastric Cancer Prognosis
Taeil Son et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A New pN Staging System Based on Both the Number and Anatomic Location of Metastatic Lymph Nodes in Gastric Cancer
Chen Jianhui et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh et al.
LANCET ONCOLOGY (2014)
Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival
Hamid Reza Raziee et al.
GASTRIC CANCER (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
Johan L. Dikken et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Significance of Microscopic Positive Margins for Gastric Cancer Patients with Potentially Curative Resection
Zhe Sun et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
Mitsuru Sasako et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year expereince at a single institute
Byoung Chul Cho et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
